N6, N6-Dimethyladenosine (Standard)
N6, N6-Dimethyladenosine (Standard) is the analytical standard of N6, N6-Dimethyladenosine. This product is intended for research and analytical applications. N6, N6-Dimethyladenosine, a modified ribonucleoside, is an endogenous A3 adenosine receptor ligand. N6, N6-Dimethyladenosine is an AKT inhibitor with antitumor effects. N6, N6-Dimethyladenosine targets SARS-CoV-2 entry protein ADAM17. N6, N6-Dimethyladenosine robustly inhibits AKT signaling in a variety of non-small cell lung cancer cell lines.
Product Specifications
CAS Number
2620-62-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Adenosine Receptor; Akt; Nucleoside Antimetabolite/Analog; Reference Standards; SARS-CoV
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; GPCR/G Protein; Others; PI3K/Akt/mTOR
Field of Research
Cancer; Infection
Purity
99.94
Smiles
O[C@H]1[C@@H](O)[C@H](N2C(N=CN=C3N(C)C)=C3N=C2)O[C@@H]1CO
Molecular Formula
C12H17N5O4
Molecular Weight
295.29
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, sealed storage, away from light and moisture
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD19 (B-Lymphocyte Marker) (CD19/3116), CF594 conjugate, 0.1mg/mL
